Skip to content
Genenta Science (Nasdaq: GNTA) logo

Genenta Science (Nasdaq: GNTA) Alternatives & Competitors

12 companies similar to Genenta Science (Nasdaq: GNTA) — Genenta is a clinical stage immuno-oncology company

Companies similar to Genenta Science (Nasdaq: GNTA)

Minerva Biotechnologies logo — alternative to Genenta Science (Nasdaq: GNTA)

Minerva Biotechnologies

We see the future first

Kiromic Biopharma, Inc. logo — alternative to Genenta Science (Nasdaq: GNTA)

Kiromic Biopharma, Inc.

Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...

Carisma Therapeutics logo — alternative to Genenta Science (Nasdaq: GNTA)

Carisma Therapeutics

Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors

Alpheus Medical, Inc logo — alternative to Genenta Science (Nasdaq: GNTA)

Alpheus Medical, Inc

Changing the way cancer is treated.

Rival Readout

Competing with Genenta Science (Nasdaq: GNTA)? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Nkarta, Inc. logo — alternative to Genenta Science (Nasdaq: GNTA)

Nkarta, Inc.

A New Way Forward for Autoimmune Disease

Vor Bio logo — alternative to Genenta Science (Nasdaq: GNTA)

Vor Bio

Vor Bio's vision is to cure blood cancers through cell and genome engineering.

Altheia Science logo — alternative to Genenta Science (Nasdaq: GNTA)

Altheia Science

Altheia Science develops treatments for autoimmune diseases and cancer using innovative to...

Enterome logo — alternative to Genenta Science (Nasdaq: GNTA)

Enterome

Delivering the promise of immunotherapy

Trillium Therapeutics Inc. logo — alternative to Genenta Science (Nasdaq: GNTA)

Trillium Therapeutics Inc.

Clinical stage immuno-oncology company developing innovative therapies for the treatment o...

ImmunoCellular Therapeutics Ltd logo — alternative to Genenta Science (Nasdaq: GNTA)

ImmunoCellular Therapeutics Ltd

Pioneering immune-based therapies to harness the body's defenses against cancer through ad...

MetiMedi Co., Ltd. logo — alternative to Genenta Science (Nasdaq: GNTA)

MetiMedi Co., Ltd.

MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...

Celularity Inc. logo — alternative to Genenta Science (Nasdaq: GNTA)

Celularity Inc.

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectiou...

About Genenta Science (Nasdaq: GNTA)

Genenta Science is a biotechnology startup based in Italy, founded in 2014, with a focus on developing a proprietary hematopoietic stem cell therapy for solid tumor cancers. Their flagship product, Temferon™, involves ex-vivo gene transfer into autologous Tie2+ hematopoietic stem/progenitor cells to deliver immunomodul...

Business keywords

Hematopoietic Stem Cell Therapy, Solid Tumor Cancers, Gene Therapy, Immunotherapy, Cell Therapy, Clinical-Stage Biotech, Glioblastoma Multiforme, Cancer Treatment, Immuno-Oncology, Tie2+ Hematopoietic Stem Cells, Phase 1/2a Clinical Trial, MGMT Gene Promoter, Temferon, Ex-Vivo Gene Transfer

Frequently Asked Questions

Companies similar to Genenta Science (Nasdaq: GNTA) include Minerva Biotechnologies, Kiromic Biopharma, Inc., Carisma Therapeutics, Alpheus Medical, Inc, Nkarta, Inc.. They work in Biotechnology and Health Care and share Genenta Science (Nasdaq: GNTA)'s focus on cancer treatment, immunotherapy and cell therapy.
Bounce Watch lists 12 companies that share Genenta Science (Nasdaq: GNTA)'s industries and are closest to it in business tags, services, target customers, business model and size.
Genenta Science is a biotechnology startup based in Italy, founded in 2014, with a focus on developing a proprietary hematopoietic stem cell therapy for solid tumor cancers. Their flagship product, Temferon™, involves ex-vivo gene transfer into autologous Tie2+ hematopoietic stem/progenitor cells to deliver immunomodul...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Genenta Science (Nasdaq: GNTA): 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Genenta Science (Nasdaq: GNTA) on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout